Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion type Assertion NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_head.
- NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_provenance.
- NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion evidence source_evidence_literature NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_provenance.
- NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion SIO_000772 23806066 NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_provenance.
- NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion wasDerivedFrom befree-20150227 NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_provenance.
- NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion wasGeneratedBy ECO_0000203 NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_provenance.